Neogenomics NEO
NASDAQ NEO
$19.28 -0.13 (-0.67%)
As of: Sep 22, 2026 · 11:38 AM EDT

Neogenomics (NEO) Cash from Financing Activities (2010 - 2026)

Neogenomics' (NEO) quarterly Cash from Financing Activities came in at -$12.2 million in Q2 2026, up 93.95% on a YoY basis from -$6.3 million in Q2 2025, and down 3522.49% quarter-over-quarter from -$338000.0 in Q1 2026.

Analysis

Neogenomics (NEO) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Neogenomics (NEO) has reported Cash from Financing Activities for 17 consecutive years, with -$12.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Financing Activities rose 93.95% year-over-year to -$12.2 million; the trailing twelve-month figure through Jun 2026 stood at -$11.4 million (up 94.3% YoY), and the FY2025 full-year result was -$200.3 million, down 4410.98% from the prior year.
  • Cash from Financing Activities fell to -$12.2 million in Q2 2026 per NEO's latest filing, from -$338000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $6.1 million in Q1 2022 and bottomed at -$202.4 million in Q2 2025.
  • Historically, Cash from Financing Activities has averaged -$10.7 million across 5 years, with a median of $980000.0 in 2022.
  • The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities soared 2971.88% in 2024, then slumped 10396.69% in 2025.
  • Over 5 years, Cash from Financing Activities stood at $1.8 million in 2022, then retreated by 29.52% to $1.3 million in 2023, then slumped by 45.91% to $687000.0 in 2024, then slumped by 37.26% to $431000.0 in 2025, then slumped by 2940.84% to -$12.2 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$12.2 million, -$338000.0, and $431000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 12.21 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn -229.00 Mn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn -919.90 Mn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn 23.01 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 97.12 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn -36.90 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn -2.41 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 6.09 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 142.19 Mn
10 Neogenomics 2.55 Bn 2.40 Bn 91.88 Mn -12.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.24 Mn
Mar 31, 2026 -338,000.00
Dec 31, 2025 431,000.00
Sep 30, 2025 765,000.00
Jun 30, 2025 -202.43 Mn
Mar 31, 2025 949,000.00
Dec 31, 2024 687,000.00
Sep 30, 2024 1.18 Mn
Jun 30, 2024 1.97 Mn
Mar 31, 2024 816,000.00
Dec 31, 2023 1.27 Mn
Sep 30, 2023 1.84 Mn
Jun 30, 2023 64,000.00
Mar 31, 2023 1.38 Mn
Dec 31, 2022 1.80 Mn
Sep 30, 2022 2.96 Mn
Jun 30, 2022 1.01 Mn
Mar 31, 2022 6.06 Mn
Dec 31, 2021 2.46 Mn
Sep 30, 2021 -6.72 Mn
API Access

Neogenomics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NEO&period=max&api_key=YOUR_API_KEY